Ubiquitin specific protease 1 inhibitors (AIGEN Sciences)

N/A

Report date: 2025/07/01 10:20:08

NME

Base Information

Drug NameUbiquitin specific protease 1 inhibitors (AIGEN Sciences)

Drug Alias NameN/A

ClassificationOther

Mechanisms of ActionUbiquitin carboxyl-terminal hydrolase 1 inhibitors

TargetsUbiquitin carboxyl-terminal hydrolase 1

Therapy Area/IndicationsOvarian NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAIGEN Sciences Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsOvarian NeoplasmsBreast Neoplasms

Inactive IndicationsN/A

ATC CodeN/A